• About Us
    • Overview
    • Our Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Cell Manufacturing Advisory Board
    • Strategic Partners
  • Technology
    • Allogeneic Cell Therapy Platform
    • Oncolytic Virus Combinations
    • CD30 CAR-T Cell Therapy
    • Manufacturing
  • Pipeline
    • TT11X Allogeneic CD30 CAR EBVSTs
    • TT16 HER2 CAR Ts + CAdVEC
    • TT11 CD30 CAR Ts
    • TT11 CD30 CAR Ts + Nivolumab
    • Expanded Access
    • Scientific Publications
  • Investors & Media
    • Press Releases & Events
    • Interviews
  • Careers
  • Contact Us

What are you looking for?

Tessa Therapeutics – Cancer Immunotherapy Treatments
Tessa Therapeutics – Cancer Immunotherapy Treatments
Tessa Therapeutics – Cancer Immunotherapy Treatments
  • About Us
    • Overview
    • Our Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Cell Manufacturing Advisory Board
    • Strategic Partners
  • Technology
    • Allogeneic Cell Therapy Platform
    • Oncolytic Virus Combinations
    • CD30 CAR-T Cell Therapy
    • Manufacturing
  • Pipeline
    • TT11X Allogeneic CD30 CAR EBVSTs
    • TT16 HER2 CAR Ts + CAdVEC
    • TT11 CD30 CAR Ts
    • TT11 CD30 CAR Ts + Nivolumab
    • Expanded Access
    • Scientific Publications
  • Investors & Media
    • Press Releases & Events
    • Interviews
  • Careers
  • Contact Us

Interview Series: In Pursuit of Cancer Cure: Conversations with Immunotherapy Advocates – Dr Malcolm Brenner

by tessathe on April 12, 2019 in news-videos

<< Back to Interviews

Previous Reading
Our Scientific Co-founder, Dr Malcolm Brenner Shares the Story about the Early Days of Tessa and its Scientific Foundation
Next Reading
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PRESS RELEASES & EVENTS
  • CAREERS
  • CONTACT US

SITEMAP          PRIVACY POLICY

© 2021 Tessa Therapeutics Ltd. All rights reserved.